LINDSAY BRIGITTE UTE enters CARDIFF ONCOLOGY, INC. with 27.43K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.43K | Direct |
| Total | 27.43K | 27.43K direct |
Stock Options
DirectUnderlying shares
1.75K
Shares owned
N/A
Exercise price
21.60
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
95.04K
Shares owned
N/A
Exercise price
3.51
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
96.19K
Shares owned
N/A
Exercise price
2.60
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
131.57K
Shares owned
N/A
Exercise price
2.50
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
154.70K
Shares owned
N/A
Exercise price
7.98
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
90.29K
Shares owned
N/A
Exercise price
1.72
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
166.32K
Shares owned
N/A
Exercise price
3.58
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying shares
89.47K
Shares owned
N/A
Exercise price
2.48
Expiration
—
Exercise window
—
Underlying
825.33K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 21.60 | — | — | 1.75K | N/A |
| Stock Options Direct | Common Stock | 3.51 | — | — | 95.04K | N/A |
| Stock Options Direct | Common Stock | 2.60 | — | — | 96.19K | N/A |
| Stock Options Direct | Common Stock | 2.50 | — | — | 131.57K | N/A |
| Stock Options Direct | Common Stock | 7.98 | — | — | 154.70K | N/A |
| Stock Options Direct | Common Stock | 1.72 | — | — | 90.29K | N/A |
| Stock Options Direct | Common Stock | 3.58 | — | — | 166.32K | N/A |
| Stock Options Direct | Common Stock | 2.48 | — | — | 89.47K | N/A |
| Total | 825.33K | 0.00 | ||||